Paxil and Birth Defects

Share This:

Antidepressant Drug Paxil Linked to Birth Defects

An increased risk of severe birth defects, including septal heart defects and other congenital abnormalities, is associated with use of the anti-depressant drug Paxil (paroxetine) by pregnant women, particularly during the first trimester of pregnancy. The FDA advised doctors not to prescribe Paxil in women who are in the first three months of pregnancy or are planning pregnancy, unless other treatment options are not appropriate.

Paxil During Pregnancy

Paxil poses a particular risk for pregnant women. It is the only SSRI on the market that is classified by the FDA as a Category D drug. Category D means that studies in pregnant women have demonstrated a risk to the fetus. Paxil birth defects may include:

  • Congenital heart defects such as atrial and ventricular septal defects, hypoplastic left heart syndrome, tricuspid atresia, and pulmonary stenosis
  • Other birth defects such as neural-tube defects, craniosynostosis, infant omphalocele, congenital foot deformity (i.e. club foot), anal atresia, and certain lung defects (i.e. PPHN)

Paxil Lawsuit

If you or your loved one has suffered a Paxil injury, you may consider a Paxil lawsuit. Contact us today. We have a Paxil lawyer who may be able to help you.